# US 2016/0258964 A1 · Luminescent resonance energy transfer sensors for non-invasively and continuously monitoring glucose for diabetes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0258964 A1
- Document ID: US20160258964A1
- Status: Published application
- Kind: A1
- Application number: 14/867,910
- Filed: 2016-01-13
- Published: 2016-09-08
- Earliest claimed: 2014-09-26
- Assignees: Jin Zhang
- Inventors: Jin Zhang; Xianbin Wang
- Web page: https://patentgrep.com/patent/US20160258964A1

## CPC

- G01N 33/66: involving blood sugars, e.g. galactose
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/1477: non-invasive
- B82Y 15/00: Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
- G02B 1/043: {Contact lenses}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- G02B: OPTICAL ELEMENTS, SYSTEMS OR APPARATUS

## Abstract

The present disclosure discloses a non-invasive wireless glucose level monitoring device. The device is fitted into a contact lens and can analyze glucose levels in tear fluid. The results of the analysis can be continuously transmitted to a nearby receiver and uploaded to a computer, mobile device or server.

## Claims

### Claim 1

An apparatus for the detection of glucose levels in body fluids, comprising
a transparent substrate;
a luminescent resonance energy transfer (LRET) optical sensor embedded in the transparent substrate capable of generating electromagnetic radiation in response to interaction with glucose contained in a body fluid; and
a signal detector located within a detection range of the luminescent resonance energy transfer optical sensor.

### Claim 2 (depends on 1)

The apparatus of claim 1 wherein the luminescent resonance energy transfer optical sensor is a nanostructured LRET pair-conjugated glucose recognizer.

### Claim 3 (depends on 2)

The apparatus of claim 2 wherein the nanostructured LRET pair-conjugated glucose recognizer includes a light emitting donor, a light absorbing and emitting acceptor, glucose recognizer coupled to the acceptor, linker molecule linking the light emitting donor to the glucose recognizer, and wherein the interaction with glucose includes the linker molecule being replaced by glucose.

### Claim 4 (depends on 2)

The apparatus of claim 2 wherein the nanostructured LRET pair-conjugated glucose recognizer includes a light emitting donor, a light absorbing and emitting acceptor, an glucose recognizer coupled to the light emitting donor and linked to the light absorbing and emitting acceptor by a linker molecule, and wherein the interaction with glucose includes the linker molecule being replaced by glucose.

### Claim 5 (depends on 3)

The apparatus of claim 3, wherein the linker molecule is any one or combination of dextran, β-cyclodextrin, phosphate, and an amino acid linker.

### Claim 6 (depends on 4)

The apparatus of claim 4, wherein the linker molecule is any one or combination of dextran, β-cyclodextrin, phosphate, and an amino acid linker.

### Claim 7 (depends on 3)

The apparatus of claim 3, wherein the glucose recognizer includes any one or combination of a glucose binding protein (GBP), Concanavalin A (Con A), glucose oxidase enzyme, and boronic acid.

### Claim 8 (depends on 4)

The apparatus of claim 4, wherein the glucose recognizer includes any one or combination of a glucose binding protein (GBP), glucose oxidase enzyme, Concanavalin A (Con A), and boronic acid.

### Claim 9 (depends on 3)

The apparatus of claim 3, wherein the luminescent resonance energy transfer optical sensor is any one of
a fluorescent excited LRET sensor in which the donor is made of a fluorescence nanomaterial, and
a bioluminescent resonance energy transfer sensor in which the donor is a bioluminescent protein.

### Claim 10 (depends on 4)

The apparatus of claim 4, wherein the luminescent resonance energy transfer optical sensor is any one of
a fluorescent excited LRET sensor in which the donor is made of a fluorescence nanomaterial, and
is a bioluminescent resonance energy transfer sensor in which the donor is a bioluminescent protein.

### Claim 11 (depends on 3)

The apparatus of claim 3, wherein the luminescent resonance energy transfer optical sensor is a near infrared/infrared (NIR/IR) excited LRET sensor in which the donor is made of magnetic element-doped upconversion nanomaterials.

### Claim 12 (depends on 4)

The apparatus of claim 4, wherein the luminescent resonance energy transfer optical sensor is a near infrared/infrared (NIR/IR) excited LRET sensor in which the donor is made of magnetic element-doped upconversion nanomaterials.

### Claim 13 (depends on 3)

The apparatus of claim 3, wherein the light absorbing and light emitting acceptor includes any one or combination of porous fluorescent silica nanoparticles, quantum dots, silicon, ZnO nanoparticles, nanorods, metallic nanoparticles and fluorescent molecules.

### Claim 14 (depends on 4)

The apparatus of claim 4, wherein the light absorbing and light emitting acceptor includes any one or combination of porous fluorescent silica nanoparticles, quantum dots, silicon, ZnO nanoparticles, nanorods, metallic nanoparticles and fluorescent molecules.

### Claim 15 (depends on 1)

The apparatus of claim 1, wherein the electromagnetic radiation is a fluorescent emission of visible-near infrared wavelength.

### Claim 16 (depends on 1)

The apparatus of claim 1, wherein the signal detector is a fluorescence camera configured to detect fluorescence images and provide a fluorescence spectral response.

### Claim 17 (depends on 1)

The apparatus according to claim 1 wherein said body fluid is tears, and wherein said transparent substrate is a hydrogel-based contact lens.

### Claim 18 (depends on 1)

The apparatus according to claim 1 wherein said body fluid is urine, and wherein said transparent substrate is any one of a hydrogel-based material, polyurethane, glass and polydimethylsiloxane.

### Claim 19 (depends on 1)

The apparatus according to claim 1 wherein said body fluid is saliva, and wherein said transparent substrate is made from any one of a hydrogel-based material, polyurethane and polydimethylsiloxane.

### Claim 20 (depends on 1)

The apparatus according to claim 1 including a hydrophilic coating deposited on the LRET sensor.

### Claim 21 (depends on 20)

The apparatus according to claim 20 wherein the hydrophilic coating is deposited on the LRET sensor through any one of a spin-coating and matrix-assisted pulsed laser evaporation process to prevent protein-sticking and to provide biocompatibility.

### Claim 22 (depends on 20)

The apparatus according to claim 20 wherein the hydrophilic coating is any one or derivatives of polyethylene glycol (PEG), poly(vinylpyrrolidone) (PVP), poly(ethylene oxide) (PEO), phos-phorylcholine (PC)-containing polymers, and carboxymethyl cellulose.

### Claim 23 (depends on 3)

The apparatus of claim 3, wherein the transparent substrate includes at least two reference control areas which do not interact with glucose, a first of said at least two reference control areas having no embedded luminescent resonance energy transfer (LRET) optical sensor embedded therein such that it acts as a negative control which provides a lowest fluorescent signal corresponding to fluorescence of the substrate itself, and wherein a second of the at least two reference control areas having only the light emitting donor mounted thereon and provides a maximum luminescent signal such that it acts as a positive control.

### Claim 24 (depends on 23)

The apparatus of claim 23, wherein a detected fluorescence spectrum emitted due to interaction of the LRET optical sensor with glucose in a body fluid is calibrated by an algebra method executed on a computer processor as a function of glucose concentration in comparison with fluorescence signals of the negative control and positive control.

### Claim 25 (depends on 23)

The apparatus of claim 23, wherein the captured fluorescence image is calibrated by an algebra method executed on a computer processor as a function of glucose concentration in comparison with fluorescence pixel intensities of the negative control and positive control.
